{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:16:02Z","timestamp":1792793762246,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701280"],"award-info":[{"award-number":["81701280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471319"],"award-info":[{"award-number":["81471319"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671301"],"award-info":[{"award-number":["81671301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271445"],"award-info":[{"award-number":["81271445"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chongqing Postgraduate Research Innovation","award":["CYB17115"],"award-info":[{"award-number":["CYB17115"]}]},{"name":"First Affiliated Hospital of Chongqing Medical University"},{"DOI":"10.13039\/501100002799","name":"Capital Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002799","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chongqing Key Laboratory of Neurology"},{"name":"Laboratory Animal Center of Chongqing Medical University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.neuropharm.2018.06.010","type":"journal-article","created":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T14:42:07Z","timestamp":1528555327000},"page":"170-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Overexpression of miRNA-137 in the brain suppresses seizure activity and neuronal excitability: A new potential therapeutic strategy for epilepsy"],"prefix":"10.1016","volume":"138","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanlin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonggui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1494-0223","authenticated-orcid":false,"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.06.010_bib1","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0515","article-title":"MicroRNAs and synaptic plasticity\u2013a mutual relationship","volume":"369","author":"Aksoy-Aksel","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12883-015-0494-y","article-title":"The economic impact of epilepsy: a systematic review","volume":"15","author":"Allers","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000222775","article-title":"Refractory epilepsy: a clinically oriented review","volume":"62","author":"Beleza","year":"2009","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1126\/science.1097065","article-title":"Acquired dendritic channelopathy in temporal lobe epilepsy","volume":"305","author":"Bernard","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib6","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1523\/JNEUROSCI.0633-10.2010","article-title":"Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy","volume":"30","author":"Brandt","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib7","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1523\/JNEUROSCI.22-15-06650.2002","article-title":"Axon sprouting in a model of temporal lobe epilepsy creates a predominantly excitatory feedback circuit","volume":"22","author":"Buckmaster","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib8","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1528-1157.1996.tb00541.x","article-title":"The pilocarpine model of epilepsy in mice","volume":"37","author":"Cavalheiro","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib9","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/j.1528-1167.2008.01644.x","article-title":"Erythropoietin reduces epileptogenic processes following status epilepticus","volume":"49","author":"Chu","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib10","doi-asserted-by":"crossref","first-page":"28594","DOI":"10.1074\/jbc.R115.696468","article-title":"Thematic minireview series: molecular mechanisms of synaptic plasticity","volume":"290","author":"Colbran","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuron.2005.10.034","article-title":"Threshold behavior in the initiation of hippocampal population bursts","volume":"49","author":"de la Prida","year":"2006","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neuropharm.2018.06.010_bib12","doi-asserted-by":"crossref","first-page":"9.37.1","DOI":"10.1002\/0471142301.ns0937s58","article-title":"Pentylenetetrazol (PTZ) kindling model of epilepsy","volume":"58","author":"Dhir","year":"2012","journal-title":"Curr Protoc Neurosci"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2017.02.001","article-title":"Epilepsy and synaptic proteins","volume":"45","author":"Fukata","year":"2017","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0014-4886(88)90008-8","article-title":"Characterization of the epileptiform activity induced by magnesium-free solution in rat amygdala slices: an intracellular study","volume":"101","author":"Gean","year":"1988","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0006-8993(98)00864-6","article-title":"Effects of GABAB receptor antagonism on the development of pentylenetetrazol-induced kindling in mice","volume":"809","author":"Getova","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.neuropharm.2013.10.016","article-title":"Synaptic plasticity in glutamatergic and GABAergic neurotransmission following chronic memantine treatment in an in\u00a0vitro model of limbic epileptogenesis","volume":"77","author":"He","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib17","first-page":"5","article-title":"Epigenetics and epilepsy","author":"Henshall","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2165\/11535570-000000000-00000","article-title":"Economic burden of epilepsy among the privately insured in the US","volume":"28","author":"Ivanova","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib19","article-title":"Antiepileptic treatments in developing countries","author":"Jost","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nbd.2006.02.016","article-title":"Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus","volume":"23","author":"Jung","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib21","doi-asserted-by":"crossref","first-page":"a022764","DOI":"10.1101\/cshperspect.a022764","article-title":"GABAergic synchronization in epilepsy","volume":"6","author":"Khazipov","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/1073858415608356","article-title":"The multifarious hippocampal functions of MicroRNA-137","volume":"22","author":"Kos","year":"2016","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib23","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"Suppl.\u00a05","key":"10.1016\/j.neuropharm.2018.06.010_bib24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1528-1167.2005.01021.x","article-title":"Plasticity, synaptic strength, and epilepsy: what can we learn from ultrastructural data?","volume":"46","author":"Leite","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1167.2008.01716.x","article-title":"The clinical impact of pharmacogenetics on the treatment of epilepsy","volume":"50","author":"Loscher","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib26","doi-asserted-by":"crossref","first-page":"A15","DOI":"10.1038\/399a015","article-title":"Emerging insights into the genesis of epilepsy","volume":"399","author":"McNamara","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib27","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1523\/JNEUROSCI.4437-15.2016","article-title":"17beta-Estradiol acutely potentiates glutamatergic synaptic transmission in the Hippocampus through distinct mechanisms in males and females","volume":"36","author":"Oberlander","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neuroscience.2006.02.076","article-title":"Repeated brief epileptic seizures by pentylenetetrazole cause neurodegeneration and promote neurogenesis in discrete brain regions of freely moving adult rats","volume":"140","author":"Park","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fncel.2014.00300","article-title":"Diffusion dynamics of synaptic molecules during inhibitory postsynaptic plasticity","volume":"8","author":"Petrini","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.neuropharm.2018.06.010_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1528-1167.2010.02602.x","article-title":"Therapeutic approaches to epileptogenesis\u2013hope on the horizon","volume":"51","author":"Pitkanen","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.expneurol.2010.03.014","article-title":"The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy","volume":"224","author":"Polascheck","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib32","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/cn500149w","article-title":"Deciphering the function and regulation of microRNAs in Alzheimer's disease and Parkinson's disease","volume":"5","author":"Qiu","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0920-1211(96)00046-0","article-title":"Pentylenetetrazol-induced kindling: early involvement of excitatory and inhibitory systems","volume":"26","author":"Rocha","year":"1996","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/jnnp.61.5.433","article-title":"Epidemiology of the epilepsies","volume":"61","author":"Sander","year":"1996","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib36","doi-asserted-by":"crossref","first-page":"12448","DOI":"10.1038\/srep12448","article-title":"MicroRNA-124 and -137 cooperativity controls caspase-3 activity through BCL2L13 in hippocampal neural stem cells","volume":"5","author":"Schouten","year":"2015","journal-title":"Sci. Rep."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2018.06.010_bib37","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.eplepsyres.2006.01.016","article-title":"Classification criteria of epileptic seizures and syndromes","volume":"70","author":"Seino","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib38","first-page":"1","article-title":"CNTNAP4 impacts epilepsy through GABAA receptors regulation: evidence from temporal lobe epilepsy patients and mouse models","author":"Shangguan","year":"2017","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib39","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/nn.4023","article-title":"The schizophrenia risk gene product miR-137 alters presynaptic plasticity","volume":"18","author":"Siegert","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib40","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/stem.431","article-title":"MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1","volume":"28","author":"Smrt","year":"2010","journal-title":"Stem Cell."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib41","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1152\/jn.1995.73.4.1706","article-title":"Recurrent spontaneous seizure activity in hippocampal neuronal networks in culture","volume":"73","author":"Sombati","year":"1995","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib42","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s12035-014-8803-9","article-title":"Causes and consequences of MicroRNA dysregulation in neurodegenerative diseases","volume":"51","author":"Tan","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib43","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1126\/science.1165209","article-title":"Activation of pannexin-1 hemichannels augments aberrant bursting in the hippocampus","volume":"322","author":"Thompson","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib44","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/erm.2016.3","article-title":"The microRNA miR-124 suppresses seizure activity and regulates CREB1 activity","volume":"18","author":"Wang","year":"2016","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuro.2016.01.005","article-title":"Impaired hippocampal synaptic plasticity and NR2A\/2B expression ratio in remifentanil withdrawal rats","volume":"53","author":"Wang","year":"2016","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib46","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1113\/jphysiol.2007.138131","article-title":"Factors defining a pacemaker region for synchrony in the hippocampus","volume":"584","author":"Wittner","year":"2007","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib47","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1111\/j.1528-1167.2011.03390.x","article-title":"Coexistence of schizophrenia and epilepsy: record-linkage studies","volume":"53","author":"Wotton","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2018.06.010_bib48","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2017.01.157","article-title":"Chronic metformin treatment facilitates seizure termination","volume":"484","author":"Yang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib49","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.3390\/ijms15023262","article-title":"miR-137: a new player in schizophrenia","volume":"15","author":"Yin","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib50","doi-asserted-by":"crossref","first-page":"37713","DOI":"10.1038\/srep37713","article-title":"NR4A1 knockdown suppresses seizure activity by regulating surface expression of NR2B","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2018.06.010_bib51","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s11064-014-1364-5","article-title":"miR-146a and miR-196a2 polymorphisms in patients with ischemic stroke in the northern Chinese Han population","volume":"39","author":"Zhu","year":"2014","journal-title":"Neurochem. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818302867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818302867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T08:30:46Z","timestamp":1604392246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818302867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":51,"alternative-id":["S0028390818302867"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.06.010","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of miRNA-137 in the brain suppresses seizure activity and neuronal excitability: A new potential therapeutic strategy for epilepsy","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}